Form 8-K - Current report:
SEC Accession No. 0001213900-25-003026
Filing Date
2025-01-13
Accepted
2025-01-13 16:34:33
Documents
52
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227457-8k_protara.htm   iXBRL 8-K 45144
2 OPINION OF SULLIVAN & CROMWELL LLP ea022745701ex5-1_protara.htm EX-5.1 7087
3 CORPORATE PRESENTATION, DATED JANUARY 13, 2025 ea022745701ex99-1_protara.htm EX-99.1 51116
4 PRESS RELEASE, DATED JANUARY 13, 2025 ea022745701ex99-2_protara.htm EX-99.2 27698
5 GRAPHIC ex99-1_001.jpg GRAPHIC 492269
6 GRAPHIC ex99-1_002.jpg GRAPHIC 945092
7 GRAPHIC ex99-1_003.jpg GRAPHIC 454276
8 GRAPHIC ex99-1_004.jpg GRAPHIC 489289
9 GRAPHIC ex99-1_005.jpg GRAPHIC 528441
10 GRAPHIC ex99-1_006.jpg GRAPHIC 137623
11 GRAPHIC ex99-1_007.jpg GRAPHIC 759453
12 GRAPHIC ex99-1_008.jpg GRAPHIC 746336
13 GRAPHIC ex99-1_009.jpg GRAPHIC 126984
14 GRAPHIC ex99-1_010.jpg GRAPHIC 435420
15 GRAPHIC ex99-1_011.jpg GRAPHIC 582179
16 GRAPHIC ex99-1_012.jpg GRAPHIC 579205
17 GRAPHIC ex99-1_013.jpg GRAPHIC 569037
18 GRAPHIC ex99-1_014.jpg GRAPHIC 654125
19 GRAPHIC ex99-1_015.jpg GRAPHIC 411321
20 GRAPHIC ex99-1_016.jpg GRAPHIC 502785
21 GRAPHIC ex99-1_017.jpg GRAPHIC 565199
22 GRAPHIC ex99-1_018.jpg GRAPHIC 481642
23 GRAPHIC ex99-1_019.jpg GRAPHIC 587193
24 GRAPHIC ex99-1_020.jpg GRAPHIC 171168
25 GRAPHIC ex99-1_021.jpg GRAPHIC 511344
26 GRAPHIC ex99-1_022.jpg GRAPHIC 747573
27 GRAPHIC ex99-1_023.jpg GRAPHIC 697518
28 GRAPHIC ex99-1_024.jpg GRAPHIC 629276
29 GRAPHIC ex99-1_025.jpg GRAPHIC 456670
30 GRAPHIC ex99-1_026.jpg GRAPHIC 121400
31 GRAPHIC ex99-1_027.jpg GRAPHIC 604771
32 GRAPHIC ex99-1_028.jpg GRAPHIC 709254
33 GRAPHIC ex99-1_029.jpg GRAPHIC 517170
34 GRAPHIC ex99-1_030.jpg GRAPHIC 324111
35 GRAPHIC ex99-1_031.jpg GRAPHIC 290901
36 GRAPHIC ex99-1_032.jpg GRAPHIC 355862
37 GRAPHIC ex99-1_033.jpg GRAPHIC 605315
38 GRAPHIC ex99-1_034.jpg GRAPHIC 459605
39 GRAPHIC ex99-1_035.jpg GRAPHIC 656194
40 GRAPHIC ex99-2_001.jpg GRAPHIC 7741
  Complete submission text file 0001213900-25-003026.txt   25007865

Data Files

Seq Description Document Type Size
41 XBRL SCHEMA FILE tara-20250113.xsd EX-101.SCH 3018
42 XBRL LABEL FILE tara-20250113_lab.xml EX-101.LAB 34240
43 XBRL PRESENTATION FILE tara-20250113_pre.xml EX-101.PRE 22361
54 EXTRACTED XBRL INSTANCE DOCUMENT ea0227457-8k_protara_htm.xml XML 3707
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

EIN.: 204580525 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 25526743
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)